SCHEMBL6818975

SCHEMBL6818975

CNS(=O)(=O)c1cc2c(C(=O)Nc3ccc(C#N)cc3C(=O)O)noc2cc1-c1cccnc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.38
CYP11B1 P15538 1/20 0.38
CYP11B2 P19099 1/20 0.38
GSK3A P49840 2/20 0.38
GSK3B P49841 2/20 0.38
ALB P02768 2/20 0.37
ATR Q13535 1/20 0.36
GAK O14976 1/20 0.36
STK16 O75716 1/20 0.36
PIM1 P11309 1/20 0.36
AXL P30530 1/20 0.36
NEK2 P51955 1/20 0.36
STK3 Q13188 1/20 0.36
STK11 Q15831 1/20 0.36
AAK1 Q2M2I8 1/20 0.36
BMP2K Q9NSY1 1/20 0.36
TNIK Q9UKE5 1/20 0.36
NEK1 Q96PY6 1/20 0.35
LRRK2 Q5S007 1/20 0.35
CHRNB2 P17787 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6819285 0.93 ALB (0.40) GSK3AGSK3BALBBRD4
SCHEMBL6817796 0.92 PPARG (0.37) PPARGCYP11B1CYP11B2GSK3AGSK3B
SCHEMBL6818761 0.91 ALB (0.39) PPARGGSK3AGSK3BALBLRRK2
SCHEMBL6817333 0.91 PPARG (0.39) PPARGCYP11B1CYP11B2GSK3AGSK3B
SCHEMBL6818174 0.90 STING1 (0.39) GSK3AGSK3BALBLRRK2BRD4
SCHEMBL6818640 0.88 PPARG (0.39) PPARGCYP11B1CYP11B2GSK3AGSK3B
SCHEMBL6821747 0.86 BRD4 (0.39) GSK3AGSK3BALBLRRK2BRD4
SCHEMBL6818843 0.85 PPARG (0.42) PPARGCYP11B1CYP11B2GSK3AGSK3B
SCHEMBL6818405 0.84 ALB (0.37) ALBBRD4PDE10A
SCHEMBL6819061 0.84 ALB (0.38) GSK3AGSK3BALBBRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004018428-A1 ANTIBACTERIAL BENZOIC ACID DERIVATIVES PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO disclosed